WW International Adds Novo Nordisk's Wegovy to Weight Management Platform

MT Newswires Live
Jan 05

WW International (WW) said Monday it is incorporating the newly US Food and Drug Administration-approved daily Wegovy pill by Novo Nordisk (NVO) into its weight health GLP-1 platform.

The addition of the oral medication provides an alternative to injectable treatments for members seeking clinically supported options.

Participants in the Weight Watchers Med+ program can obtain the oral medication starting at $149 per month.

The integrated service model pairs the medication with behavioral coaching and digital tools intended to manage side effects and improve results, according to the company.

Shares of WW International were up more than 5% in recent trading.

Price: 33.10, Change: +1.66, Percent Change: +5.28

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10